Discovery Life Sciences To Acquire Gentest Business From Corning Incorporated
Apr 05, 2022•over 3 years ago
Acquiring Company
Discovery Life Sciences
Acquired Company
Business
Description
Discovery Life SciencesTM (Discovery), the biospecimen and biomarker specialistsTM, announced today that it has acquired the Gentest® business unit, part of Corning Incorporated's Life Sciences business. The acquisition of Gentest complements Discovery's recent acquisition of In Vitro ADMET Laboratories, LLC (IVAL) in December of last year and establishes Discovery as a leading provider of in vitro drug experimental systems to the pharmaceutical and life sciences industry.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed